Impact of Amitryptiline on Migraine Disability Assessment Score
Aim: Migraine headache is a common disorder, several drugs have been tried as a prophylaxis to reduce the attacks of headache. Aim of this study is to see the impact of amitriptyline on quality of life in migraneurs using Migraine Disability Assessment Score. Materials and Methods: In this stud...
Main Authors: | Kuldeep Moras, Hanock Nischal |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2014-09-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/4854/7546_CE(Ra)_F(Sh)_PF1(PAK)_PFA(Sh)_PF2(PAG).pdf |
Similar Items
-
MIDAS (Migraine Disability Assessment): a valuable tool for work-site identification of migraine in workers in Brazil
by: Yara Dadalti Fragoso -
Translation, cross-cultural adaptation and reliability of the German version of the migraine disability assessment (MIDAS) questionnaire
by: Thomas Benz, et al.
Published: (2018-03-01) -
Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine
by: Francesca Schiano di Cola, et al.
Published: (2023-02-01) -
Migraine awareness, prevalence, triggers, and impact on university students: a cross-sectional study
by: Ayah Rustom, et al.
Published: (2022-10-01) -
Impact of fremanezumab on disability outcomes in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies
by: Peter McAllister, et al.
Published: (2022-08-01)